PTC Therapeutics, Inc. (PTCT) Stock Price, News, Quote & History ...
Find the latest PTC Therapeutics, Inc. (PTCT) stock quote, history, news and other vital information to help you with your stock trading and investing.
PTC Therapeutics, Inc. (PTCT) Stock Price, News, Quote & History ...
Find the latest PTC Therapeutics, Inc. (PTCT) stock quote, history, news and other vital information to help you with your stock trading and investing.
PTC Therapeutics, Inc. (PTCT) Latest Stock News & Headlines
Get the latest PTC Therapeutics, Inc. (PTCT) stock news and headlines to help you in your trading and investing decisions.
PTC Therapeutics, Inc. (PTCT) - Yahoo Finance
See PTC Therapeutics, Inc. (PTCT) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.
PTC Therapeutics, Inc. (PTCT) Stock Historical Prices & Data
Discover historical prices for PTCT stock on Yahoo Finance. View daily, weekly or monthly format back to when PTC Therapeutics, Inc. stock was issued.
PTC Therapeutics, Inc. (PTCT) Interactive Stock Chart - Yahoo …
Interactive Chart for PTC Therapeutics, Inc. (PTCT), analyze all the data with a huge range of indicators.
PTC Therapeutics, Inc. (PTCT) - Yahoo Finance
It markets Upstaza, a gene therapy with the brand name Kebilidi in the United States. PTC Therapeutics, Inc. was incorporated in 1998 and is headquartered in Warren, New Jersey.
PTCT Interactive Stock Chart - Yahoo Finance
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your …
Why PTC Therapeutics (PTCT) Stock Is Rallying Today
Feb 3, 2025 · PTC Therapeutics (PTCT) is advancing 8% after investment bank Cantor Fitzgerald' hiked its price target on the drug maker's shares to $113 from $76. Cantor kept an Overweight …
PTC Therapeutics (PTCT) Surges 16.5%: Is This an Indication of …
Oct 9, 2024 · PTC Therapeutics (PTCT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't …